Hickey et al., 1996 - Google Patents
Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosolsHickey et al., 1996
- Document ID
- 8971557875136888926
- Author
- Hickey A
- Martonen T
- Yang Y
- Publication year
- Publication venue
- Pharmaceutica Acta Helvetiae
External Links
Snippet
Pharmaceutical inhalation aerosols intended to deliver drugs to the lungs may be sampled by inertial devices, that divide particle distributions into pre-calibrated diameters. A characteristic particle diameter (D50) is prescribed, below which the aerosol mass is …
- 239000000443 aerosol 0 title abstract description 54
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/062—Desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hickey et al. | Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols | |
| Longest et al. | Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways | |
| Brain et al. | Deposition of aerosol in the respiratory tract | |
| Johnson et al. | Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma: efficacy and pulmonary deposition | |
| Asgharian et al. | Modeling age-related particle deposition in humans | |
| Morawska et al. | Experimental study of the deposition of combustion aerosols in the human respiratory tract | |
| Thompson | Drug delivery to the small airways | |
| Martonen | Measurement of particle dose distribution in a model of a human larynx and tracheobronchial tree | |
| Clark et al. | Modelling the deposition of inhaled powdered drug aerosols | |
| NEWMAN | How well do in vitro particle size measurements predict drug delivery in vivo? | |
| MARTONEN et al. | Growth rate measurements and deposition modelling of hygroscopic aerosols in human tracheobronchial models | |
| Schroeter et al. | Hygroscopic growth and deposition of inhaled secondary cigarette smoke in human nasal pathways | |
| Clark et al. | In vitro testing of pharmaceutical aerosols and predicting lung deposition from in vitro measurements | |
| Davies et al. | An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified ‘Kirk Lung’ | |
| Longest et al. | Small airway absorption and microdosimetry of inhaled corticosteroid particles after deposition | |
| Ho et al. | Evaluation of four breath-enhanced nebulizers for home use | |
| Balásházy et al. | Aerosol drug delivery optimization by computational methods for the characterization of total and regional deposition of therapeutic aerosols in the respiratory system | |
| Majoral et al. | Humidified and heated cascade impactor for aerosol sizing | |
| O'Doherty et al. | Aerosols for therapy and diagnosis | |
| Martonen et al. | Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns | |
| Yeates et al. | Particle deposition and clearance in the bronchial tree | |
| Clark et al. | Mouth and oropharyngeal deposition of pharmaceutical aerosols | |
| Harnor et al. | Effect of vapour pressure on the deposition pattern from solution phase metered dose inhalers | |
| Schroeter et al. | Effects of formulation variables on lung dosimetry of albuterol sulfate suspension and beclomethasone dipropionate solution metered dose inhalers | |
| Austin et al. | A model for deposition of stable and unstable aerosols in the human respiratory tract |